Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_12-cv-01917/USCOURTS-caed-1_12-cv-01917-3/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: DARVOCET, DARVON AND PROPOXYPHENE

PRODUCTS LIABILITY LITIGATION MDL No. 2226

REMAND ORDER

Before the Panel: Defendants in the seven actions before the Panel move under Panel Rule * 1

10.2 to vacate our order, entered at the suggestions of the transferee judge, conditionally remanding

the actions listed on the attached Schedule A to their respective transferor courts. Plaintiffs in those

actions oppose the motion.

The parties have raised a number of arguments as to whether these actions should remain in

the MDL. Because we find that proceedings in MDL No. 2226 essentially are complete, we need

not reach the parties’ other arguments about the propriety vel non of remand. The Panel has not

transferred a new action to this MDL in more than two years, and most MDL No. 2226 actions were

resolved some time ago, while these seven actions are in their infancy. We find that transferring

these actions to the MDL, in which all other proceedings have concluded, would not promote

convenience or efficiency. 

 Judge Charles R. Breyer and Judge Ellen Segal Huvelle did not participate in the Panel’s *

decision. 

 Endo Pharmaceuticals Holdings Inc.; Endo Pharmaceuticals Inc.; Generics International 1

(US Parent), Inc.; Generics International (US), Inc.; Generics Bidco I, LLC; Generics Bidco II, LLC;

Vintage Pharmaceuticals, LLC; Xanodyne Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.;

Mallinckrodt Inc.; Covidien Inc.; Watson Pharmaceuticals, Inc.; Brenn Distribution, Inc. f/k/a Propst

Distribution, Inc. f/k/a Qualitest Pharmaceuticals, Inc.; Brenn Manufacturing, Inc. f/k/a Vintage

Pharmaceuticals, Inc.; Mylan Inc.; Mylan Pharmaceuticals Inc.; McKesson Corporation; Cornerstone

Biopharma, Inc.; Cornerstone Biopharma Holdings, LLC f/k/a Cornerstone BioPharma Holdings,

Inc.; Aristos Pharmaceuticals, Inc.; AAIPharma, Inc.; AAIPharma, LLC; AAIPharma Development

Services, Inc.; and Neosan Pharmaceuticals, Inc.

FILED AND CERTIFIED

ROBERT R. CARR, CLERK

U.S. DISTRICT COURT

EASTERN DISTRICT OF KENTUCKY

Date:

By:

Deputy Clerk

$%FBSCPSO

Case 1:12-cv-01917-LJO-SKO Document 44 Filed 02/04/16 Page 1 of 3
-2-

IT IS THEREFORE ORDERED that pursuant to 28 U.S.C. § 1407, these actions are

remanded to their respective transferor courts as set forth in Schedule A.

PANEL ON MULTIDISTRICT LITIGATION

 

 Sarah S. Vance

 Chair

Marjorie O. Rendell Lewis A. Kaplan 

R. David Proctor Catherine D. Perry

Case 1:12-cv-01917-LJO-SKO Document 44 Filed 02/04/16 Page 2 of 3
IN RE: DARVOCET, DARVON AND PROPOXYPHENE

PRODUCTS LIABILITY LITIGATION MDL No. 2226

SCHEDULE A

Eastern District of California

BOWEN, ET AL. v. MCKESSON CORPORATION ET AL., C.A. No. 1:12-01906

MITCHELL, ET AL. v. MCKESSON CORPORATION, ET AL., C.A. No. 1:12-01907

BALTAZAR, ET AL. v. MCKESSON CORPORATION, ET AL., C.A. No. 1:12-01917

Southern District of California

DADOUSH, ET AL. v. MCKESSON CORPORATION, ET AL., C.A. No. 3:12-02815

GOMEZ, ET AL. v. MCKESSON CORPORATION, ET AL., C.A. No. 3:12-02816

SAUNDERS, ET AL. v. MCKESSON CORPORATION, ET AL., C.A. No. 3:12-02817

JASMIN, ET AL. v. MCKESSON CORPORATION, ET AL., C.A. No. 3:12-02820

Case 1:12-cv-01917-LJO-SKO Document 44 Filed 02/04/16 Page 3 of 3